Log in or register
Share on LinkedInShare on LinkedIn

ARTICLE · 30 SEPTEMBER 2021

Enterprise Connect 2021

Levine, Blaszak, Block & Boothby
Explore more from Levine, Blaszak, Block & Boothby

TC2 Director Joe Schmidt was a featured presenter at 2021's Enterprise Connect conference this September, where he presented on Re-building the WAN for the Post-Pandemic Office.

United StatesCorporate/Commercial Law
Joe Schmidt
Joe Schmidt

TC2 Director Joe Schmidt was a featured presenter at 2021's Enterprise Connect conference this September, where he presented on Re-building the WAN for the Post-Pandemic Office.

You can watch the presentation here.

Companies are poised for profound transformation as they reconsider where work gets done. How will this change impact your wide-area bandwidth consumption, and how do you ensure continued cost savings and service quality? Joe provided practical tips on technology decisions and contracting strategies that can help you navigate the rebuild of your WAN to fit your new reality.

Takeaways:

  • How should you start revisiting your WAN strategy to respond to changes in office use?

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

Register for freeORLog in

View source

Related Articles

Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics

Read more about

Related Comparative Guides

See more popular content from

Article

Healthcare Trends & Transactions Q2 2026

Healthcare M&A activity maintained steady momentum through Q2 2026, driven by physician practice consolidation, AI-enabled technology acquisitions, and strategic outpatient expansion. Private equity investment persisted despite intensifying regulatory scrutiny of MSO arrangements, while digital health buyers paid significant premiums for platforms demonstrating production-grade AI capabilities and proprietary data assets.
United StatesCorporate/Commercial Law
Bass, Berry & Sims PLC
Bass, Berry & Sims PLC
Article

CLIENT ALERT: 2026 Mid-Year Update On SEC And CFTC Enforcement

The SEC and CFTC have fundamentally shifted their enforcement approach in 2026, moving away from high-volume technical violations toward targeted actions addressing serious fraud and market manipulation. This mid-year update examines new leadership priorities, enhanced inter-agency coordination, revised cooperation policies, the elimination of "no-deny" settlement provisions, and a landmark Supreme Court ruling on disgorgement that collectively reshape the regulatory landscape for market participants.
United StatesCorporate/Commercial Law
Sher Tremonte
Sher Tremonte
Article

Sanofi And Regeneron Expand Immunology Collaboration In Deal Worth Up To $8 Billion

Sanofi and Regeneron Pharmaceuticals announce a major expansion of their immunology partnership, committing up to $8 billion to develop and commercialize four long-acting antibodies targeting key inflammatory pathways. The collaboration includes a $1 billion upfront payment and milestone-based payments, with both companies sharing development costs and future profits equally.
United StatesCorporate/Commercial Law
Goodwin Procter LLP
Goodwin Procter LLP